文献速递传染病防控与疫情报告卫生政策与健康促进

博尔萨家庭计划对结核病治疗结局的影响:前瞻性队列研究

Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study.
PubMed 文献 · Lancet Glob Health · 2018-12-21

在巴西七城市42个卫生中心前瞻性招募≥18岁新启动抗结核治疗者1239人,按是否领取博尔萨家庭计划补助分为暴露组196人与非暴露组1043人,随访6个月治疗结局。作者认为该计划单独对结核治疗结局有直接作用,可助力WHO终止结核病策略目标。

要点

  • 领取博尔萨家庭计划补助与结核病治愈率提高、脱失率下降相关。
  • 队列6个月时非暴露组治愈912/1043(87%),暴露组治愈173/196(88%)。
  • 非暴露组脱失103/1043(10%),暴露组脱失17/196(9%)。

核心结论

  • 博尔萨家庭计划单独对结核病治疗结局具有直接效应,可能对实现WHO终止结核病策略目标有重要贡献。

研究设计与样本

  • 前瞻性队列研究,2014年3月1日至2017年4月30日在巴西七城市42个卫生中心招募≥18岁新启动结核治疗者,共纳入1239人。
  • 按是否领取博尔萨家庭计划补助分为暴露组196人(16%)与非暴露组1043人(84%),随访6个月记录治疗结局。
  • 采用Pearson χ2检验与ANOVA比较组间结局,以logit模型估计倾向评分,并用多项回归模型评估补助对结局的效应。

主要发现

  • 6个月治疗时非暴露组治愈912/1043(87%)、脱失103/1043(10%)、死亡25/1043(3%),3/1043(<1%)出现耐药结核。
  • 暴露组治愈173/196(88%)、脱失17/196(9%)、死亡6/196(3%)。

临床怎么用

  • 在结核病治疗管理中可评估患者社会保护需求,将现金转移补助纳入支持治愈、减少脱失的综合措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Social protection interventions might improve tuberculosis outcomes and could help to control the epidemic in Brazil. The aim of this study was to evaluate the independent effect of the Bolsa Familia Programme (BFP) on tuberculosis treatment outcomes in Brazil. METHODS: We prospectively recruited and followed up individuals (aged ≥18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in Brazil, between March 1, 2014, and April 30, 2017. Patients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. Patients were separated into two groups according to BFP beneficiary status: BFP (exposed) or non-BFP (not exposed). Treatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. Pearson's χ2 test and ANOVA were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit model. We used multinomial regression models to evaluate the effect of the BFP on tuberculosis treatment outcomes. FINDINGS: 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the BFP and 1043 (84%) were not. After 6 months of treatment, 912 (87%) of 1043 patients in the non-BFP group and 173 (88%) of 196 patients in the BFP group were cured of tuberculosis, 103 (10%) patients in the non-BFP group and 17 (9%) patients in the BFP group had dropped out, and 25 (3%) patients in the non-BFP group and six (3%) patients in the BFP group had died. Three (<1%) of 1043 patients in the non-BFP group developed drug-resistant tuberculosis. Being a BFP beneficiary had a positive effect for cure (average effect 0·076 [95% CI 0·037 to 0·11]) and a negative effect for dropout (-0·070 [-0·105 to 0·036]) and death (-0·002 [-0·021 to 0·017]). INTERPRETATION: BFP alone had a direct effect on tuberculosis treatment outcome and could greatly contribute to the goals of the WHO End TB Strategy. FUNDING: Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT).

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Oliosi JGN, Reis-Santos B, Locatelli RL, et al. Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. Lancet Glob Health. 2018. PMID: 30584050. doi:10.1016/S2214-109X(18)30478-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。